| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone H3K9 acetyltransferase activity | 9.66e-05 | 3 | 114 | 2 | GO:0043992 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to membrane | 6.82e-06 | 237 | 114 | 9 | GO:1905475 | |
| GeneOntologyBiologicalProcess | positive regulation of hydrolase activity | HSPE1 ARHGAP24 PDPK1 LARS1 DOCK10 SLC39A10 GSN SNX13 PLAA APH1A AKT1 AKT2 | 2.08e-05 | 499 | 114 | 12 | GO:0051345 |
| GeneOntologyBiologicalProcess | regulation of hydrolase activity | SERPINB7 HSPE1 HSP90B1 ARHGAP24 PDPK1 LARS1 DOCK10 SLC39A10 CMYA5 GSN ITIH5 SNX13 PLAA APH1A AKT1 AKT2 | 2.63e-05 | 878 | 114 | 16 | GO:0051336 |
| GeneOntologyBiologicalProcess | peptidyl-threonine phosphorylation | 4.31e-05 | 115 | 114 | 6 | GO:0018107 | |
| GeneOntologyBiologicalProcess | peptidyl-serine phosphorylation | 5.27e-05 | 307 | 114 | 9 | GO:0018105 | |
| GeneOntologyBiologicalProcess | peptidyl-threonine modification | 6.86e-05 | 125 | 114 | 6 | GO:0018210 | |
| GeneOntologyBiologicalProcess | peptidyl-serine modification | 7.07e-05 | 319 | 114 | 9 | GO:0018209 | |
| GeneOntologyBiologicalProcess | actin filament severing | 1.26e-04 | 18 | 114 | 3 | GO:0051014 | |
| GeneOntologyBiologicalProcess | negative regulation of long-chain fatty acid import across plasma membrane | 1.80e-04 | 4 | 114 | 2 | GO:0010748 | |
| GeneOntologyBiologicalProcess | membrane raft polarization | 1.80e-04 | 4 | 114 | 2 | GO:0001766 | |
| GeneOntologyBiologicalProcess | negative regulation of long-chain fatty acid import into cell | 1.80e-04 | 4 | 114 | 2 | GO:0140213 | |
| GeneOntologyCellularComponent | ATAC complex | 5.36e-05 | 14 | 113 | 3 | GO:0140672 | |
| GeneOntologyCellularComponent | retromer, cargo-selective complex | 1.73e-04 | 4 | 113 | 2 | GO:0030906 | |
| GeneOntologyCellularComponent | cell cortex | 1.87e-04 | 371 | 113 | 9 | GO:0005938 | |
| Domain | Acetyltransf_1 | 1.07e-05 | 23 | 114 | 4 | PF00583 | |
| Domain | Villin/Gelsolin | 1.21e-05 | 8 | 114 | 3 | IPR007122 | |
| Domain | GEL | 1.21e-05 | 8 | 114 | 3 | SM00262 | |
| Domain | GNAT_dom | 1.51e-05 | 25 | 114 | 4 | IPR000182 | |
| Domain | GNAT | 1.51e-05 | 25 | 114 | 4 | PS51186 | |
| Domain | Hist_acetylase_PCAF | 3.69e-05 | 2 | 114 | 2 | IPR016376 | |
| Domain | PCAF_N | 3.69e-05 | 2 | 114 | 2 | IPR009464 | |
| Domain | PCAF_N | 3.69e-05 | 2 | 114 | 2 | PF06466 | |
| Domain | Recoverin | 6.06e-05 | 13 | 114 | 3 | IPR028846 | |
| Domain | Gelsolin | 7.68e-05 | 14 | 114 | 3 | PF00626 | |
| Domain | Gelsolin-like_dom | 7.68e-05 | 14 | 114 | 3 | IPR007123 | |
| Domain | - | 1.02e-04 | 40 | 114 | 4 | 3.40.630.30 | |
| Domain | Vps26-related | 1.10e-04 | 3 | 114 | 2 | IPR028934 | |
| Domain | Rhs_assc_core | 1.10e-04 | 3 | 114 | 2 | IPR022385 | |
| Domain | Vps26 | 1.10e-04 | 3 | 114 | 2 | PF03643 | |
| Domain | Acyl_CoA_acyltransferase | 1.62e-04 | 45 | 114 | 4 | IPR016181 | |
| Domain | EF-hand_7 | 1.72e-04 | 85 | 114 | 5 | PF13499 | |
| Domain | Tox-GHH_dom | 2.20e-04 | 4 | 114 | 2 | IPR028916 | |
| Domain | Tox-GHH | 2.20e-04 | 4 | 114 | 2 | PF15636 | |
| Domain | Ten_N | 2.20e-04 | 4 | 114 | 2 | IPR009471 | |
| Domain | Ten_N | 2.20e-04 | 4 | 114 | 2 | PF06484 | |
| Domain | TENEURIN_N | 2.20e-04 | 4 | 114 | 2 | PS51361 | |
| Domain | EF-hand_1 | 3.41e-04 | 152 | 114 | 6 | PF00036 | |
| Domain | YD | 3.65e-04 | 5 | 114 | 2 | IPR006530 | |
| Domain | - | 4.08e-04 | 24 | 114 | 3 | 3.40.20.10 | |
| Domain | ADF-H/Gelsolin-like_dom | 4.08e-04 | 24 | 114 | 3 | IPR029006 | |
| Domain | EFh | 4.19e-04 | 158 | 114 | 6 | SM00054 | |
| Domain | EF_HAND_2 | 5.42e-04 | 231 | 114 | 7 | PS50222 | |
| Domain | EF_hand_dom | 5.56e-04 | 232 | 114 | 7 | IPR002048 | |
| Domain | - | 1.11e-03 | 261 | 114 | 7 | 1.10.238.10 | |
| Domain | Pkinase_C | 1.48e-03 | 37 | 114 | 3 | IPR017892 | |
| Domain | TPR_7 | 1.61e-03 | 10 | 114 | 2 | PF13176 | |
| Domain | S_TKc | 1.62e-03 | 359 | 114 | 8 | SM00220 | |
| Domain | Kinase-like_dom | AKT3 CDK12 PDPK1 CSNK1G1 ETNK1 AKT1 AKT2 PRKDC CSNK2A3 TRIB1 | 1.79e-03 | 542 | 114 | 10 | IPR011009 |
| Domain | SH3_2 | 1.90e-03 | 86 | 114 | 4 | PF07653 | |
| Domain | SH3_2 | 1.90e-03 | 86 | 114 | 4 | IPR011511 | |
| Domain | EF-hand-dom_pair | 1.91e-03 | 287 | 114 | 7 | IPR011992 | |
| Domain | DHR-1_domain | 1.96e-03 | 11 | 114 | 2 | IPR027007 | |
| Domain | DHR_2 | 1.96e-03 | 11 | 114 | 2 | PS51651 | |
| Domain | DHR_1 | 1.96e-03 | 11 | 114 | 2 | PS51650 | |
| Domain | DHR-2 | 1.96e-03 | 11 | 114 | 2 | PF06920 | |
| Domain | DOCK | 1.96e-03 | 11 | 114 | 2 | IPR026791 | |
| Domain | DOCK_C | 1.96e-03 | 11 | 114 | 2 | IPR010703 | |
| Domain | DOCK-C2 | 1.96e-03 | 11 | 114 | 2 | PF14429 | |
| Domain | DHR-2 | 1.96e-03 | 11 | 114 | 2 | IPR027357 | |
| Domain | Pkinase_C | 2.14e-03 | 42 | 114 | 3 | PF00433 | |
| Domain | TPR-contain_dom | 2.27e-03 | 150 | 114 | 5 | IPR013026 | |
| Domain | FAD-dep_OxRdtase | 2.34e-03 | 12 | 114 | 2 | IPR006076 | |
| Domain | DAO | 2.34e-03 | 12 | 114 | 2 | PF01266 | |
| Domain | Pkinase | 2.34e-03 | 381 | 114 | 8 | PF00069 | |
| Domain | NHL | 2.76e-03 | 13 | 114 | 2 | PS51125 | |
| Domain | TPR-like_helical_dom | 3.08e-03 | 233 | 114 | 6 | IPR011990 | |
| Domain | HEAT | 3.14e-03 | 48 | 114 | 3 | PF02985 | |
| Domain | TPR_REGION | 3.43e-03 | 165 | 114 | 5 | PS50293 | |
| Domain | TPR | 3.43e-03 | 165 | 114 | 5 | PS50005 | |
| Domain | EF_Hand_1_Ca_BS | 4.40e-03 | 175 | 114 | 5 | IPR018247 | |
| Domain | CarboxyPept-like_regulatory | 4.73e-03 | 17 | 114 | 2 | IPR008969 | |
| Domain | AGC-kinase_C | 4.85e-03 | 56 | 114 | 3 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 4.85e-03 | 56 | 114 | 3 | PS51285 | |
| Domain | S_TK_X | 4.85e-03 | 56 | 114 | 3 | SM00133 | |
| Domain | HEAT | 5.35e-03 | 58 | 114 | 3 | IPR000357 | |
| Pathway | REACTOME_SARS_COV_2_TARGETS_HOST_INTRACELLULAR_SIGNALLING_AND_REGULATORY_PATHWAYS | 6.16e-07 | 12 | 86 | 4 | M45022 | |
| Pathway | PID_PI3KCI_AKT_PATHWAY | 2.11e-06 | 35 | 86 | 5 | M249 | |
| Pathway | KEGG_MEDICUS_VARIANT_LOSS_OF_NKX3_1_TO_PI3K_SIGNALING_PATHWAY | 2.17e-06 | 5 | 86 | 3 | M48999 | |
| Pathway | SA_PTEN_PATHWAY | 2.89e-06 | 17 | 86 | 4 | M12771 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MAGI_PTEN_SIGNALING_PATHWAY | 4.33e-06 | 6 | 86 | 3 | M47523 | |
| Pathway | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | 5.35e-06 | 42 | 86 | 5 | M17541 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PI3K_TO_PI3K_SIGNALING_PATHWAY | 7.54e-06 | 7 | 86 | 3 | M47407 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ACH_CHRN_PI3K_SIGNALING_PATHWAY | 7.54e-06 | 7 | 86 | 3 | M47790 | |
| Pathway | REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING | 8.68e-06 | 22 | 86 | 4 | M13897 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION | 8.68e-06 | 22 | 86 | 4 | MM15656 | |
| Pathway | REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING | 1.05e-05 | 23 | 86 | 4 | MM14993 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PI3K_SIGNALING_PATHWAY | 1.20e-05 | 8 | 86 | 3 | M47399 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PI3K_SIGNALING_PATHWAY | 1.20e-05 | 8 | 86 | 3 | M47394 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_PI3K_SIGNALING_PATHWAY | 1.20e-05 | 8 | 86 | 3 | M47395 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_PI3K_SIGNALING_PATHWAY | 1.20e-05 | 8 | 86 | 3 | M47404 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_PI3K_SIGNALING_PATHWAY | 1.20e-05 | 8 | 86 | 3 | M47405 | |
| Pathway | KEGG_MEDICUS_REFERENCE_P4_PR_PI3K_SIGNALING_PATHWAY | 1.20e-05 | 8 | 86 | 3 | M47803 | |
| Pathway | REACTOME_RUNX2_REGULATES_GENES_INVOLVED_IN_CELL_MIGRATION | 1.20e-05 | 8 | 86 | 3 | M27806 | |
| Pathway | KEGG_MEDICUS_VARIANT_TGFA_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 1.20e-05 | 8 | 86 | 3 | M47482 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 1.20e-05 | 8 | 86 | 3 | M47498 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_RET_TO_PI3K_SIGNALING_PATHWAY | 1.20e-05 | 8 | 86 | 3 | M47715 | |
| Pathway | REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA | 1.48e-05 | 25 | 86 | 4 | M14301 | |
| Pathway | REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA | 1.74e-05 | 26 | 86 | 4 | MM15017 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_AKT1_E17K_IN_CANCER | 1.74e-05 | 26 | 86 | 4 | M27558 | |
| Pathway | WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION | 1.74e-05 | 26 | 86 | 4 | M48092 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_PI3K_SIGNALING_PATHWAY | 1.79e-05 | 9 | 86 | 3 | M47397 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PI3K_SIGNALING_PATHWAY | 1.79e-05 | 9 | 86 | 3 | M47392 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KRAS_NRAS_TO_PI3K_SIGNALING_PATHWAY | 1.79e-05 | 9 | 86 | 3 | M47391 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_PI3K_SIGNALING_PATHWAY | 1.79e-05 | 9 | 86 | 3 | M47402 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MEMBRANE_INITIATED_PROGESTERONE_SIGNALING_PATHWAY | 1.79e-05 | 9 | 86 | 3 | M47802 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_MET_TO_PI3K_SIGNALING_PATHWAY | 1.79e-05 | 9 | 86 | 3 | M47490 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TGFA_EGFR_PI3K_SIGNALING_PATHWAY | 1.79e-05 | 9 | 86 | 3 | M47481 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_NUCLEAR_EVENTS_DOWNSTREAM_OF_ESR_MEMBRANE_SIGNALING | 1.79e-05 | 9 | 86 | 3 | MM15666 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ICOSLG_ICOS_PI3K_SIGNALING_PATHWAY | 1.79e-05 | 9 | 86 | 3 | M47972 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY | 2.04e-05 | 27 | 86 | 4 | M27422 | |
| Pathway | SIG_IL4RECEPTOR_IN_B_LYPHOCYTES | 2.04e-05 | 27 | 86 | 4 | M1718 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGFR_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 2.55e-05 | 10 | 86 | 3 | M47400 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HGF_MET_PI3K_SIGNALING_PATHWAY | 2.55e-05 | 10 | 86 | 3 | M47401 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CD80_CD86_CD28_PI3K_SIGNALING_PATHWAY | 2.55e-05 | 10 | 86 | 3 | M47615 | |
| Pathway | REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_NUCLEUS | 2.55e-05 | 10 | 86 | 3 | M27095 | |
| Pathway | REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_NUCLEUS | 2.55e-05 | 10 | 86 | 3 | MM14778 | |
| Pathway | KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS | 2.58e-05 | 96 | 86 | 6 | M16121 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY | 3.13e-05 | 30 | 86 | 4 | MM15170 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NICOTINE_NNK_TO_PI3K_SIGNALING_PATHWAY | 3.49e-05 | 11 | 86 | 3 | M47797 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KITLG_KIT_PI3K_SIGNALING_PATHWAY | 3.49e-05 | 11 | 86 | 3 | M47403 | |
| Pathway | KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_PI3K_SIGNALING_PATHWAY | 3.49e-05 | 11 | 86 | 3 | M47406 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF2_IGF1R_PI3K_SIGNALING_PATHWAY | 3.49e-05 | 11 | 86 | 3 | M47484 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EREG_EGFR_PI3K_SIGNALING_PATHWAY | 3.49e-05 | 11 | 86 | 3 | M47499 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NRG_ERBB4_PI3K_SIGNALING_PATHWAY | 3.49e-05 | 11 | 86 | 3 | M47756 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_PI3K_SIGNALING_PATHWAY_N01339 | 3.49e-05 | 11 | 86 | 3 | M47791 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AREG_EGFR_PI3K_SIGNALING_PATHWAY | 3.49e-05 | 11 | 86 | 3 | M47501 | |
| Pathway | REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING | 4.08e-05 | 32 | 86 | 4 | M14309 | |
| Pathway | REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING | 4.62e-05 | 33 | 86 | 4 | MM15027 | |
| Pathway | REACTOME_CD28_CO_STIMULATION | 4.62e-05 | 33 | 86 | 4 | M11725 | |
| Pathway | KEGG_MEDICUS_VARIANT_ERBB2_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 4.63e-05 | 12 | 86 | 3 | M47393 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_PI3K_SIGNALING_PATHWAY_N01350 | 4.63e-05 | 12 | 86 | 3 | M47798 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY | 4.63e-05 | 12 | 86 | 3 | M47558 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY | 4.63e-05 | 12 | 86 | 3 | M47559 | |
| Pathway | REACTOME_REGULATION_OF_LOCALIZATION_OF_FOXO_TRANSCRIPTION_FACTORS | 4.63e-05 | 12 | 86 | 3 | MM15657 | |
| Pathway | REACTOME_REGULATION_OF_LOCALIZATION_OF_FOXO_TRANSCRIPTION_FACTORS | 4.63e-05 | 12 | 86 | 3 | M27939 | |
| Pathway | REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL | 4.63e-05 | 12 | 86 | 3 | MM14777 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING | 4.63e-05 | 12 | 86 | 3 | MM14550 | |
| Pathway | REACTOME_CD28_CO_STIMULATION | 5.21e-05 | 34 | 86 | 4 | MM14992 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PI3K_SIGNALING_PATHWAY | 6.00e-05 | 13 | 86 | 3 | M47398 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF_IGF1R_PI3K_SIGNALING_PATHWAY | 6.00e-05 | 13 | 86 | 3 | M47603 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING | 6.00e-05 | 13 | 86 | 3 | M549 | |
| Pathway | REACTOME_REGULATION_OF_TP53_DEGRADATION | 6.55e-05 | 36 | 86 | 4 | MM15339 | |
| Pathway | SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES | 6.55e-05 | 36 | 86 | 4 | M1315 | |
| Pathway | REACTOME_REGULATION_OF_TP53_EXPRESSION_AND_DEGRADATION | 7.31e-05 | 37 | 86 | 4 | M27641 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_PI3K_SIGNALING_PATHWAY | 7.60e-05 | 14 | 86 | 3 | M47390 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ASSOCIATION_WITH_CO_FACTORS | 7.60e-05 | 14 | 86 | 3 | MM15341 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ASSOCIATION_WITH_CO_FACTORS | 7.60e-05 | 14 | 86 | 3 | M27638 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF_IGFR_PI3K_NFKB_SIGNALING_PATHWAY | 7.60e-05 | 14 | 86 | 3 | M47467 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PI3K_NFKB_SIGNALING_PATHWAY | 7.60e-05 | 14 | 86 | 3 | M47536 | |
| Pathway | REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL | 7.60e-05 | 14 | 86 | 3 | M3862 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 9.02e-05 | 39 | 86 | 4 | MM14604 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_PI3K_SIGNALING_PATHWAY | 9.46e-05 | 15 | 86 | 3 | M47389 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RELN_VLDLR_PI3K_SIGNALING_PATHWAY | 9.46e-05 | 15 | 86 | 3 | M47663 | |
| Pathway | REACTOME_ACTIVATION_OF_BAD_AND_TRANSLOCATION_TO_MITOCHONDRIA | 9.46e-05 | 15 | 86 | 3 | M26902 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_PI3K_SIGNALING_PATHWAY | 9.46e-05 | 15 | 86 | 3 | M47475 | |
| Pathway | WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS | 9.46e-05 | 15 | 86 | 3 | M48306 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BCR_BCAP_CD19_PI3K_SIGNALING_PATHWAY | 9.46e-05 | 15 | 86 | 3 | M47971 | |
| Pathway | WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES | 1.40e-04 | 17 | 86 | 3 | M48086 | |
| Pathway | SA_TRKA_RECEPTOR | 1.40e-04 | 17 | 86 | 3 | M18895 | |
| Pathway | SIG_CHEMOTAXIS | 1.59e-04 | 45 | 86 | 4 | M5193 | |
| Pathway | SIG_BCR_SIGNALING_PATHWAY | 1.73e-04 | 46 | 86 | 4 | M8626 | |
| Pathway | WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION | 1.98e-04 | 19 | 86 | 3 | M39370 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PP2A_AKT_SIGNALING_PATHWAY | 1.98e-04 | 19 | 86 | 3 | M47525 | |
| Pathway | KEGG_PROSTATE_CANCER | 2.09e-04 | 89 | 86 | 5 | M13191 | |
| Pathway | SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES | 2.59e-04 | 51 | 86 | 4 | M7955 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS | 2.69e-04 | 21 | 86 | 3 | M14966 | |
| Pathway | REACTOME_CTLA4_INHIBITORY_SIGNALING | 2.69e-04 | 21 | 86 | 3 | M5876 | |
| Pathway | REACTOME_CTLA4_INHIBITORY_SIGNALING | 2.69e-04 | 21 | 86 | 3 | MM14996 | |
| Pathway | KEGG_ENDOMETRIAL_CANCER | 2.80e-04 | 52 | 86 | 4 | M19877 | |
| Pathway | KEGG_MTOR_SIGNALING_PATHWAY | 2.80e-04 | 52 | 86 | 4 | M7561 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CD80_CD86_CTLA4_PP2A_SIGNALING_PATHWAY | 3.10e-04 | 22 | 86 | 3 | M47919 | |
| Pathway | PID_TGFBR_PATHWAY | 3.24e-04 | 54 | 86 | 4 | M286 | |
| Pathway | KEGG_NON_SMALL_CELL_LUNG_CANCER | 3.24e-04 | 54 | 86 | 4 | M19818 | |
| Pathway | WP_SIGNAL_TRANSDUCTION_OF_S1P_RECEPTOR | 3.55e-04 | 23 | 86 | 3 | MM15952 | |
| Pathway | WP_SILDENAFIL_TREATMENT | 3.55e-04 | 23 | 86 | 3 | M46455 | |
| Pubmed | 5.66e-10 | 5 | 115 | 4 | 9512493 | ||
| Pubmed | 1.69e-09 | 6 | 115 | 4 | 20186503 | ||
| Pubmed | 3.94e-09 | 7 | 115 | 4 | 21697490 | ||
| Pubmed | 3.94e-09 | 7 | 115 | 4 | 21295499 | ||
| Pubmed | DNA-PKcs, but not TLR9, is required for activation of Akt by CpG-DNA. | 1.41e-08 | 9 | 115 | 4 | 15678105 | |
| Pubmed | pVHL suppresses kinase activity of Akt in a proline-hydroxylation-dependent manner. | 2.35e-08 | 10 | 115 | 4 | 27563096 | |
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 17912369 | ||
| Pubmed | Differential activation of AKT isoforms by growth factors in human myotubes. | 3.52e-08 | 3 | 115 | 3 | 37879895 | |
| Pubmed | Differential prognostic values of the three AKT isoforms in acute myeloid leukemia. | 3.52e-08 | 3 | 115 | 3 | 38528080 | |
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 15987444 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 19825827 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 16540465 | ||
| Pubmed | Molecular alterations in AKT1, AKT2 and AKT3 detected in breast and prostatic cancer by FISH. | 3.52e-08 | 3 | 115 | 3 | 20102399 | |
| Pubmed | Distinct roles of the three Akt isoforms in lactogenic differentiation and involution. | 3.52e-08 | 3 | 115 | 3 | 18561256 | |
| Pubmed | Differential effects of Akt isoforms on somatic cell reprogramming. | 3.52e-08 | 3 | 115 | 3 | 25037569 | |
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 38396845 | ||
| Pubmed | Akt recruits Dab2 to albumin endocytosis in the proximal tubule. | 3.52e-08 | 3 | 115 | 3 | 25253241 | |
| Pubmed | AKT isoforms have distinct hippocampal expression and roles in synaptic plasticity. | 3.52e-08 | 3 | 115 | 3 | 29173281 | |
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 21590431 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 29235817 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 34296180 | ||
| Pubmed | Sex differences in the mechanism of Met5-enkephalin-induced cardioprotection: role of PI3K/Akt. | 3.52e-08 | 3 | 115 | 3 | 17982014 | |
| Pubmed | Opposing functions of Akt isoforms in lung tumor initiation and progression. | 3.52e-08 | 3 | 115 | 3 | 24722238 | |
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 20133737 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 24039187 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 16923958 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 17202487 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 26953242 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 23929892 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 19805051 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 18757368 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 25233414 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 21555366 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 32796067 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 25811375 | ||
| Pubmed | Akt/Protein kinase B is required for lymphatic network formation, remodeling, and valve development. | 3.52e-08 | 3 | 115 | 3 | 20724596 | |
| Pubmed | Akt Regulates Axon Wrapping and Myelin Sheath Thickness in the PNS. | 3.52e-08 | 3 | 115 | 3 | 27098694 | |
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 28931550 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 10579998 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 20398329 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 33325370 | ||
| Pubmed | The Akt isoforms are present at distinct subcellular locations. | 3.52e-08 | 3 | 115 | 3 | 20018949 | |
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 24247267 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 17895832 | ||
| Pubmed | Molecular cloning, expression and characterization of the human serine/threonine kinase Akt-3. | 3.52e-08 | 3 | 115 | 3 | 10491192 | |
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 17210696 | ||
| Pubmed | Role for Akt3/protein kinase Bgamma in attainment of normal brain size. | 3.52e-08 | 3 | 115 | 3 | 15713641 | |
| Pubmed | 5.50e-08 | 12 | 115 | 4 | 23275438 | ||
| Pubmed | Protein kinase Akt2/PKBβ is involved in blastomere proliferation of preimplantation mouse embryos. | 1.41e-07 | 4 | 115 | 3 | 31552693 | |
| Pubmed | Differential effects of protein kinase B/Akt isoforms on glucose homeostasis and islet mass. | 1.41e-07 | 4 | 115 | 3 | 19933838 | |
| Pubmed | 1.41e-07 | 4 | 115 | 3 | 21242979 | ||
| Pubmed | 1.41e-07 | 4 | 115 | 3 | 12149249 | ||
| Pubmed | 1.41e-07 | 4 | 115 | 3 | 19435822 | ||
| Pubmed | 1.41e-07 | 4 | 115 | 3 | 21507933 | ||
| Pubmed | 1.41e-07 | 4 | 115 | 3 | 21906027 | ||
| Pubmed | Conditional inactivation of Akt three isoforms causes tau hyperphosphorylation in the brain. | 1.41e-07 | 4 | 115 | 3 | 26227811 | |
| Pubmed | 1.41e-07 | 4 | 115 | 3 | 17942896 | ||
| Pubmed | 1.41e-07 | 4 | 115 | 3 | 30567482 | ||
| Pubmed | 1.41e-07 | 4 | 115 | 3 | 21763505 | ||
| Pubmed | 1.51e-07 | 15 | 115 | 4 | 19850877 | ||
| Pubmed | The E3 ligase TTC3 facilitates ubiquitination and degradation of phosphorylated Akt. | 3.50e-07 | 5 | 115 | 3 | 20059950 | |
| Pubmed | 3.50e-07 | 5 | 115 | 3 | 27938661 | ||
| Pubmed | 3.50e-07 | 5 | 115 | 3 | 26855332 | ||
| Pubmed | Unequal contribution of Akt isoforms in the double-negative to double-positive thymocyte transition. | 3.50e-07 | 5 | 115 | 3 | 17442925 | |
| Pubmed | 3.50e-07 | 5 | 115 | 3 | 22814751 | ||
| Pubmed | 3.50e-07 | 5 | 115 | 3 | 19875456 | ||
| Pubmed | Leptin deficiency and beta-cell dysfunction underlie type 2 diabetes in compound Akt knockout mice. | 3.50e-07 | 5 | 115 | 3 | 19289493 | |
| Pubmed | Platelet-derived growth factor protects neurons against gp120-mediated toxicity. | 3.50e-07 | 5 | 115 | 3 | 18300076 | |
| Pubmed | 3.50e-07 | 5 | 115 | 3 | 25246356 | ||
| Pubmed | 3.50e-07 | 5 | 115 | 3 | 14500673 | ||
| Pubmed | Brown fat organogenesis and maintenance requires AKT1 and AKT2. | 3.50e-07 | 5 | 115 | 3 | 30833219 | |
| Pubmed | 3.50e-07 | 5 | 115 | 3 | 11278835 | ||
| Pubmed | 3.50e-07 | 5 | 115 | 3 | 36640312 | ||
| Pubmed | Spontaneous Hepatocellular Carcinoma after the Combined Deletion of Akt Isoforms. | 3.50e-07 | 5 | 115 | 3 | 26996309 | |
| Pubmed | Neutrophil AKT2 regulates heterotypic cell-cell interactions during vascular inflammation. | 6.99e-07 | 6 | 115 | 3 | 24642468 | |
| Pubmed | mTORC2-AKT signaling to ATP-citrate lyase drives brown adipogenesis and de novo lipogenesis. | 6.99e-07 | 6 | 115 | 3 | 31996678 | |
| Pubmed | KCTD20, a relative of BTBD10, is a positive regulator of Akt. | 6.99e-07 | 6 | 115 | 3 | 24156551 | |
| Pubmed | 6.99e-07 | 6 | 115 | 3 | 14749824 | ||
| Pubmed | PI3 kinase directly phosphorylates Akt1/2 at Ser473/474 in the insulin signal transduction pathway. | 6.99e-07 | 6 | 115 | 3 | 24169049 | |
| Pubmed | 6.99e-07 | 6 | 115 | 3 | 20687898 | ||
| Pubmed | 6.99e-07 | 6 | 115 | 3 | 23746211 | ||
| Pubmed | 6.99e-07 | 6 | 115 | 3 | 12176997 | ||
| Pubmed | Stabilization of phosphofructokinase 1 platelet isoform by AKT promotes tumorigenesis. | 6.99e-07 | 6 | 115 | 3 | 29038421 | |
| Pubmed | Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival. | 6.99e-07 | 6 | 115 | 3 | 10869418 | |
| Pubmed | Identification of a proline-rich Akt substrate as a 14-3-3 binding partner. | 6.99e-07 | 6 | 115 | 3 | 12524439 | |
| Pubmed | Akt Regulates Sox10 Expression to Control Oligodendrocyte Differentiation via Phosphorylating FoxO1. | 6.99e-07 | 6 | 115 | 3 | 34385359 | |
| Pubmed | 6.99e-07 | 6 | 115 | 3 | 15616007 | ||
| Pubmed | 6.99e-07 | 6 | 115 | 3 | 23673657 | ||
| Pubmed | 6.99e-07 | 6 | 115 | 3 | 22107784 | ||
| Pubmed | Differential regulation of Akt kinase isoforms by the members of the TCL1 oncogene family. | 6.99e-07 | 6 | 115 | 3 | 11707444 | |
| Pubmed | 6.99e-07 | 6 | 115 | 3 | 21606541 | ||
| Pubmed | Protein kinase B alpha/Akt1 regulates placental development and fetal growth. | 6.99e-07 | 6 | 115 | 3 | 12783884 | |
| Pubmed | 6.99e-07 | 6 | 115 | 3 | 18160256 | ||
| Pubmed | Regulation of Akt/PKB activation by tyrosine phosphorylation. | 6.99e-07 | 6 | 115 | 3 | 11445557 | |
| Pubmed | AKT-dependent HspB1 (Hsp27) activity in epidermal differentiation. | 6.99e-07 | 6 | 115 | 3 | 17439945 | |
| Pubmed | 8.63e-07 | 397 | 115 | 10 | 21319273 | ||
| Pubmed | 1.22e-06 | 7 | 115 | 3 | 23968884 | ||
| Pubmed | 1.22e-06 | 7 | 115 | 3 | 19261608 | ||
| Pubmed | 1.22e-06 | 7 | 115 | 3 | 23604117 | ||
| Pubmed | 1.22e-06 | 7 | 115 | 3 | 23811558 | ||
| Interaction | AKT3 interactions | 5.60e-07 | 85 | 115 | 7 | int:AKT3 | |
| Interaction | SGK2 interactions | 4.49e-06 | 43 | 115 | 5 | int:SGK2 | |
| Interaction | AKT2 interactions | 1.81e-05 | 143 | 115 | 7 | int:AKT2 | |
| Interaction | PHLPP1 interactions | 2.13e-05 | 333 | 115 | 10 | int:PHLPP1 | |
| Interaction | CASP3 interactions | 3.39e-05 | 216 | 115 | 8 | int:CASP3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12p12 | 1.95e-04 | 113 | 115 | 4 | chr12p12 | |
| Cytoband | 7p21.1 | 1.39e-03 | 22 | 115 | 2 | 7p21.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7p21 | 1.49e-03 | 89 | 115 | 3 | chr7p21 | |
| Cytoband | 12p12.1 | 2.42e-03 | 29 | 115 | 2 | 12p12.1 | |
| Cytoband | 14q22.1 | 2.58e-03 | 30 | 115 | 2 | 14q22.1 | |
| Cytoband | 6q15 | 2.76e-03 | 31 | 115 | 2 | 6q15 | |
| Cytoband | 1q25.2 | 2.76e-03 | 31 | 115 | 2 | 1q25.2 | |
| GeneFamily | GCN5 related N-acetyltransferases | 2.44e-06 | 24 | 73 | 4 | 1134 | |
| GeneFamily | Gelsolin/villins | 3.49e-06 | 8 | 73 | 3 | 950 | |
| GeneFamily | ATAC complex | 1.75e-05 | 13 | 73 | 3 | 1058 | |
| GeneFamily | EF-hand domain containing | 2.88e-05 | 219 | 73 | 7 | 863 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.47e-03 | 206 | 73 | 5 | 682 | |
| GeneFamily | Lysine acetyltransferases|ATAC complex|SAGA complex|GCN5 related N-acetyltransferases | 2.10e-03 | 17 | 73 | 2 | 1059 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 2.10e-03 | 17 | 73 | 2 | 486 | |
| GeneFamily | WD repeat domain containing | 4.14e-03 | 262 | 73 | 5 | 362 | |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | CUL4B HSPE1 ASXL1 HSP90B1 VPS26B PDPK1 SNRNP35 SLC35A1 LARS1 VPS26A SART1 MAPRE1 SF3B1 PLAA STRAP APH1A AKT1 | 8.71e-06 | 1129 | 115 | 17 | M42508 |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | CUL4B HSPE1 ASXL1 HSP90B1 VPS26B PDPK1 SNRNP35 SLC35A1 LARS1 VPS26A SART1 MAPRE1 SF3B1 PLAA STRAP APH1A AKT1 | 1.21e-05 | 1158 | 115 | 17 | MM1338 |
| Coexpression | FAN_OVARY_CL15_SMALL_ANTRAL_FOLLICLE_GRANULOSA_CELL | GPR89B HSPE1 ASXL1 HSP90B1 SQLE REV3L MAPRE1 STRAP PRDX3 ETNK1 TOP1 ZC3HAV1 | 2.69e-05 | 644 | 115 | 12 | M41717 |
| Coexpression | GSE22886_NAIVE_TCELL_VS_NEUTROPHIL_UP | 2.87e-05 | 199 | 115 | 7 | M4473 | |
| Coexpression | GOLDRATH_NAIVE_VS_EFF_CD8_TCELL_UP | 2.96e-05 | 200 | 115 | 7 | M3035 | |
| Coexpression | FOURNIER_ACINAR_DEVELOPMENT_LATE_2 | 3.47e-05 | 281 | 115 | 8 | M4077 | |
| Coexpression | FORTSCHEGGER_PHF8_TARGETS_DN | CUL4B FLNB EFCAB11 NT5E PDPK1 SQLE MAPRE1 KAT2B APH1A FBXO21 ENO2 KAT14 ZC3HAV1 | 4.05e-05 | 783 | 115 | 13 | M2488 |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.29e-08 | 195 | 115 | 8 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | Control-T_cells-CD4+_T_cells|Control / group, cell type (main and fine annotations) | 6.39e-07 | 190 | 115 | 7 | 0733be5e54fe15d6d6ea51c154a95258e83f1b92 | |
| ToppCell | Control-T_cells-CD8+_T_cells|Control / group, cell type (main and fine annotations) | 8.65e-06 | 185 | 115 | 6 | 02ab64c0166c0646d1d4c6ed110ef0b75a1096d0 | |
| ToppCell | Control-T_cells|Control / group, cell type (main and fine annotations) | 9.19e-06 | 187 | 115 | 6 | f4e8e0eba58da89b56587667555a5d4754e108c7 | |
| ToppCell | Adult-Immune-T_lymphocyte|Adult / Lineage, Cell type, age group and donor | 1.10e-05 | 193 | 115 | 6 | 26df0c4c8a2355dd5503fadd07e368eb9a2bf06a | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.20e-05 | 196 | 115 | 6 | ea8eceacc5d5e1a22b77c31e7c45985dc7bb15de | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.24e-05 | 197 | 115 | 6 | 26475b9e4d6bfc0ae818dea13d139888ed7e92f1 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.24e-05 | 197 | 115 | 6 | 155e63b33302a87393ace699b2f6d73abe9c5763 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.27e-05 | 198 | 115 | 6 | a4005a49cf6709b543994ceb51ecd5dc46197fa9 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Airway-Club|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.31e-05 | 199 | 115 | 6 | 8649c2380285a668782d75eb076ce548eed0911d | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 1.35e-05 | 200 | 115 | 6 | b0ba486b55be18a4236bd2644f02352651f4b1fe | |
| ToppCell | Thalamus-Macroglia-POLYDENDROCYTE-P1-P1_1-Tnr|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.85e-05 | 73 | 115 | 4 | f2361804ed2e052efc1236d8abfa39ab7cb68dd8 | |
| ToppCell | Thalamus-Macroglia-POLYDENDROCYTE-P1-P1_1-Tnr-Polydendrocyte.Tnr.Ctps_(Ctps)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.85e-05 | 73 | 115 | 4 | 0ea6106a85b31d037c9aa16e1ad6a9bcb5b2eda9 | |
| ToppCell | P07-Mesenchymal-developing_mesenchymal_cell-mesenchymal_mature_unknown_2|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.98e-05 | 160 | 115 | 5 | 68b477525eeef99430382ff0a6745cac91364bc2 | |
| ToppCell | LPS-antiTNF-Epithelial_airway|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.12e-05 | 166 | 115 | 5 | eb942ed68677e55c46cb039046f45686d4062d7c | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Club_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.12e-05 | 166 | 115 | 5 | 1df4bdf7c773cbfa6c93d7a901f9cd3f3fe07a3d | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Club_cells-Airway|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.12e-05 | 166 | 115 | 5 | 9628522e7af8f8edca733588a364ab2454ac5ca5 | |
| ToppCell | Control-Epithelial_airway-Club_cells-Airway|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.53e-05 | 168 | 115 | 5 | ce87981f4da2779de952c2e5d2bbcdabb265e705 | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.53e-05 | 168 | 115 | 5 | b08458164d270d625b8ee390122d1c2ce8c653db | |
| ToppCell | Control-Epithelial_airway-Club_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.53e-05 | 168 | 115 | 5 | e85bc5398eb36b2b0773a8a7082e3ba740452165 | |
| ToppCell | Control-T_cells-Tregs|Control / group, cell type (main and fine annotations) | 7.75e-05 | 169 | 115 | 5 | e1e0983f31ec81b3fad5f9c6140d17f03f81a5dc | |
| ToppCell | 390C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 8.65e-05 | 173 | 115 | 5 | 1f725ff16e28636b20ef26f3fa9be8b47c89378d | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.89e-05 | 174 | 115 | 5 | 3c47d069bd836599a8d40eae485c23d4d3487517 | |
| ToppCell | Basal_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 8.89e-05 | 174 | 115 | 5 | a0060be3940043015dcc49a5157de5541aed24a1 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.38e-05 | 176 | 115 | 5 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | LA-17._Lymphocyte|World / Chamber and Cluster_Paper | 9.89e-05 | 178 | 115 | 5 | 34ec499d03cc198cfefa19a724d4c81974052f65 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 179 | 115 | 5 | e880c507f11ce75d104593a4ca29f0295f8125e8 | |
| ToppCell | LA-17._Lymphocyte|LA / Chamber and Cluster_Paper | 1.07e-04 | 181 | 115 | 5 | 3fd9f805fa46141b0fa7023ee5d8688d338635d5 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 182 | 115 | 5 | e6a734fb29105093d4cbfc3d0619a825b66da034 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 182 | 115 | 5 | ccc313ecc0bfd8e2c6bb83a565b427b2310485ec | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 182 | 115 | 5 | b9f758961fb4a586ae86fa0b25edb8ce4616d644 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.13e-04 | 183 | 115 | 5 | 2dde2fb48e7d31271c2f6b1dd74b2ab0b2cb520c | |
| ToppCell | Control-APC-like-Dendritic_cells|Control / group, cell type (main and fine annotations) | 1.13e-04 | 183 | 115 | 5 | 8f9c8e2436f18ea7c265b08e4e149e19cb513a16 | |
| ToppCell | Control-APC-like|Control / group, cell type (main and fine annotations) | 1.13e-04 | 183 | 115 | 5 | c313ac72cc9fa1583456d452393f61f0a4ca33a8 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-04 | 183 | 115 | 5 | b5ede5a0048c585b73c00e88aeddbcaf669347b1 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 186 | 115 | 5 | ed0a91f47e77fe21d4c7678d0f2a7c5f97d63dda | |
| ToppCell | 15-Airway-Epithelial-Neuroendocrine|Airway / Age, Tissue, Lineage and Cell class | 1.25e-04 | 187 | 115 | 5 | a7d2f30fe0f19e63d44603ece9890acd11b45e52 | |
| ToppCell | human_hepatoblastoma-NK.T_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.28e-04 | 188 | 115 | 5 | 71b7599e7e1d63cc0c8518c0501533755951d58f | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.28e-04 | 188 | 115 | 5 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-T_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-04 | 189 | 115 | 5 | b87d586a9570fa54f3e0c6bd4731c5badcaedae6 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-04 | 189 | 115 | 5 | 823d6debd09e440ddf36c54af24a5f20e222a21e | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-T_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-04 | 189 | 115 | 5 | 47c2b419b081d5bf75da5e3d9a0e05a70362dfe7 | |
| ToppCell | COPD|World / Disease state, Lineage and Cell class | 1.31e-04 | 189 | 115 | 5 | 53577632683686dc493a5a3fdc01887ec5c320f2 | |
| ToppCell | Fetal_29-31_weeks-Immune-T_lymphocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.34e-04 | 190 | 115 | 5 | 2a8de1cf27a9ebc3825cf9e7a489ecd064dfc7f9 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-04 | 190 | 115 | 5 | 11d3c31167ea71809b4cc3757a0c6ea54a448602 | |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | 1.34e-04 | 190 | 115 | 5 | 62a3ec1ae0829602b0569cc051210551644f1d46 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-pro_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.38e-04 | 191 | 115 | 5 | 40813c397f533c2f4a6359a77757f736b6d9e07d | |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 191 | 115 | 5 | 6cab0334f76c973880bd8d1638856f2f6e4a249a | |
| ToppCell | B_cell_maturation-CD34+_pre-plamsa|B_cell_maturation / Lineage and Cell class | 1.38e-04 | 191 | 115 | 5 | 4ee160a863d4fb9c4c9449633b9f337db8871992 | |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 191 | 115 | 5 | 850c6fff6dc795431ef534fdaa41e4ad50f7367a | |
| ToppCell | COVID-19-lung-CD4+_Treg|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.38e-04 | 191 | 115 | 5 | 5a4ad5ae5c2dbfb225158cb598ef649c26a48350 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.38e-04 | 191 | 115 | 5 | 4b50fdd310701251e64e16cd2d07ce03dbfd3e3e | |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 191 | 115 | 5 | 8b2b00202d3c98bccbae1b4a23713892fad0ff23 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 191 | 115 | 5 | 7d1595e616f6f111fc2f5bc1b179c5d67d624cc9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-04 | 191 | 115 | 5 | 5a67ff17fb4b9eff641176dff07830c9cd73754e | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.38e-04 | 191 | 115 | 5 | 75d2197076a9dfc868e8baf95bd4c5e44f438e3e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-04 | 191 | 115 | 5 | 55ab2854a02cdcfc395e49870ccb7290b5e5471d | |
| ToppCell | COVID-19-T_cells|COVID-19 / group, cell type (main and fine annotations) | 1.38e-04 | 191 | 115 | 5 | 7f64add931b64b8d35836fa6bee9ebab593844d3 | |
| ToppCell | Fetal_29-31_weeks-Immune-T_lymphocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.41e-04 | 192 | 115 | 5 | 69a2b04f03a1b82d067018379f7b8a116e954040 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.41e-04 | 192 | 115 | 5 | fd08ae787e936cfdb1ab8f19b0fd63005b462709 | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-suprabasal_interpapillary|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 192 | 115 | 5 | 44cb225392c8d07150955ecf203fbdf6021c9790 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 192 | 115 | 5 | d2c03490c5e835d0f0a732803093c64b8d4b4029 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 192 | 115 | 5 | 9ae05db5bfb8b9d3935c0328e6f2d489d2b1ebfd | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 192 | 115 | 5 | a116db7dec495e5a0ba9c7537057cd1e567d7885 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.41e-04 | 192 | 115 | 5 | bae236c9f1fac77bce28d0a9cf090100d391ff77 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 192 | 115 | 5 | 66defad13bd8e79319741e43ddb056841710b1d7 | |
| ToppCell | Monocytes-Tissue-resident_macrophages|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis | 1.44e-04 | 193 | 115 | 5 | 198552810dcac8d0ca63a78badd6702b49ff6edf | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-04 | 193 | 115 | 5 | eba3c70701b051bc1ed1f4db9270cb27a77ffc3e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-04 | 193 | 115 | 5 | 263d185af6ed80e639f864e4966268e0862c61dc | |
| ToppCell | facs-Heart-LA-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-04 | 193 | 115 | 5 | 124364adb3ded77282d449dd2cb039e6f2403a39 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-04 | 193 | 115 | 5 | 80e058c224749b5fe0ba3e944b48317c2371cb63 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-04 | 193 | 115 | 5 | b991fbbb4618401624f0b3045f0e81a606d3a763 | |
| ToppCell | facs-Heart-LA-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-04 | 194 | 115 | 5 | 34b54bea013c8c724fadae357e29953c291bfce1 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-04 | 194 | 115 | 5 | bc945450b350f597c3ff910d3a14a533d90086a8 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.48e-04 | 194 | 115 | 5 | b30379f8dc41c86c746af9930541fbb4819d8fa0 | |
| ToppCell | facs-Heart-LA-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-04 | 194 | 115 | 5 | 9a5dd7ae6de72a000cf9a0d42f6b0884fa43f345 | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-04 | 194 | 115 | 5 | 5d30d3d41d5f19cdf3077cc609aa2738762cb8c5 | |
| ToppCell | Adult-Immune-T_lymphocyte-D231|Adult / Lineage, Cell type, age group and donor | 1.48e-04 | 194 | 115 | 5 | 5c1dca33f382f37a7deb23e573578343c3b54986 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.52e-04 | 195 | 115 | 5 | ec12cfb2fce44cc2de4e198ef5af075e626f0329 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-04 | 195 | 115 | 5 | 690d6e15d7c863fc8f2d33b1f7bf86f019f415c9 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.52e-04 | 195 | 115 | 5 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | 390C-Myeloid-Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.52e-04 | 195 | 115 | 5 | ba494be431916d43c1d480f65bed674c0722c710 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-04 | 195 | 115 | 5 | 5c05e2bcea3d5d7ebe6325f7187ccf83301053d8 | |
| ToppCell | Secretory|World / shred by cell class for bronchial biopsy | 1.52e-04 | 195 | 115 | 5 | 52f8281fe0df67cec3faa780a23ed6343ed5a6ba | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-04 | 196 | 115 | 5 | 66d76249bd2770cdddff2c1fe59a016e95da2124 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-04 | 196 | 115 | 5 | c936014125b2ed5f796221b74acb77b8f8359875 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-04 | 196 | 115 | 5 | 9bd4c146fc7555e32adfa393b3a07846eb826d25 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-04 | 197 | 115 | 5 | 5bc11aff92da2a0aca8473f997fe7a99f3cae75d | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.59e-04 | 197 | 115 | 5 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | P03-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.59e-04 | 197 | 115 | 5 | 2cec938caf6ffd031cea37277071487e59b2c71c | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.59e-04 | 197 | 115 | 5 | 5c4cee914baf7cb43e9cb99cc9e3ae823856dc15 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.63e-04 | 198 | 115 | 5 | b2d295e330772bd8e24da356c75564b4297ea9c5 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.63e-04 | 198 | 115 | 5 | af399569c718f5fd971d73a7926768c9311002a3 | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial-Airway-Club|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.63e-04 | 198 | 115 | 5 | 6712216c5a7fd86b68fd45b0ff7794975f19774e | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.63e-04 | 198 | 115 | 5 | 38b37daf41d84e5bf913eb3f72963418b7c0aac6 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.63e-04 | 198 | 115 | 5 | a699b365d3b6149f13f02b2e2ae9b6fdce761848 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.63e-04 | 198 | 115 | 5 | 1408e02e053ad3406229bfe8189da03be6366e81 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.63e-04 | 198 | 115 | 5 | 3ffaea4b44067d69f954b2bd3119c88a55ab232a | |
| ToppCell | (02)_MMP9/10+-(1)_GFP|(02)_MMP9/10+ / shred by cell type by condition | 1.67e-04 | 199 | 115 | 5 | 448ba982be804007f991d469eca9d885b21ae499 | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial-Airway-Club|Control_saline / Treatment groups by lineage, cell group, cell type | 1.67e-04 | 199 | 115 | 5 | 5cc8b553a58669a30eb10845beb23983dcdf5a6a | |
| Computational | Genes in the cancer module 509. | 1.08e-04 | 14 | 74 | 3 | MODULE_509 | |
| Disease | prostate adenocarcinoma (is_implicated_in) | 5.79e-05 | 20 | 112 | 3 | DOID:2526 (is_implicated_in) | |
| Disease | prostate cancer (is_implicated_in) | 8.60e-05 | 117 | 112 | 5 | DOID:10283 (is_implicated_in) | |
| Disease | malignant astrocytoma (is_marker_for) | 8.92e-05 | 23 | 112 | 3 | DOID:3069 (is_marker_for) | |
| Disease | Myelodysplastic syndrome | 1.42e-04 | 5 | 112 | 2 | cv:C3463824 | |
| Disease | MYELODYSPLASTIC SYNDROME | 1.42e-04 | 5 | 112 | 2 | 614286 | |
| Disease | Neoplasm of uncertain or unknown behavior of ovary | 1.81e-04 | 29 | 112 | 3 | C0496920 | |
| Disease | Ovarian Carcinoma | 2.01e-04 | 30 | 112 | 3 | C0029925 | |
| Disease | free cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 3.29e-04 | 86 | 112 | 4 | EFO_0008595, EFO_0020945 | |
| Disease | Congenital disorder of glycosylation type 1q | 3.94e-04 | 8 | 112 | 2 | C4317224 | |
| Disease | heart disease (implicated_via_orthology) | 4.08e-04 | 38 | 112 | 3 | DOID:114 (implicated_via_orthology) | |
| Disease | lactate measurement | 4.40e-04 | 39 | 112 | 3 | EFO_0007745 | |
| Disease | Adenocarcinoma of large intestine | 4.99e-04 | 96 | 112 | 4 | C1319315 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 5.11e-04 | 41 | 112 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 5.11e-04 | 41 | 112 | 3 | C0858252 | |
| Disease | cancer (implicated_via_orthology) | 5.68e-04 | 268 | 112 | 6 | DOID:162 (implicated_via_orthology) | |
| Disease | Meckel-Gruber syndrome | 6.30e-04 | 10 | 112 | 2 | cv:C0265215 | |
| Disease | Congenital Disorders of Glycosylation | 6.30e-04 | 10 | 112 | 2 | C0282577 | |
| Disease | aspartate aminotransferase measurement | KIF21B FLNB CACNA2D2 PDPK1 DAB2 XKR6 TTC6 SNX13 NPHP3 ERAP2 TRIB1 | 6.62e-04 | 904 | 112 | 11 | EFO_0004736 |
| Disease | nephritis (biomarker_via_orthology) | 7.68e-04 | 11 | 112 | 2 | DOID:10952 (biomarker_via_orthology) | |
| Disease | Renal dysplasia and retinal aplasia (disorder) | 9.19e-04 | 12 | 112 | 2 | C0403553 | |
| Disease | generalised epilepsy | 1.03e-03 | 52 | 112 | 3 | EFO_0005917 | |
| Disease | Nephronophthisis | 1.08e-03 | 13 | 112 | 2 | C0687120 | |
| Disease | chenodeoxycholate measurement | 1.45e-03 | 15 | 112 | 2 | EFO_0010471 | |
| Disease | myelodysplastic syndrome (implicated_via_orthology) | 1.45e-03 | 15 | 112 | 2 | DOID:0050908 (implicated_via_orthology) | |
| Disease | Malignant Neoplasms | 1.46e-03 | 128 | 112 | 4 | C0006826 | |
| Disease | Tremor, Rubral | 1.65e-03 | 16 | 112 | 2 | C0750940 | |
| Disease | Ataxia, Appendicular | 1.65e-03 | 16 | 112 | 2 | C0750937 | |
| Disease | Ataxia, Motor | 1.65e-03 | 16 | 112 | 2 | C0278161 | |
| Disease | Ataxia, Sensory | 1.65e-03 | 16 | 112 | 2 | C0240991 | |
| Disease | Abnormal coordination | 1.65e-03 | 16 | 112 | 2 | C0520966 | |
| Disease | Ataxia, Truncal | 1.65e-03 | 16 | 112 | 2 | C0427190 | |
| Disease | ischemia (implicated_via_orthology) | 1.87e-03 | 17 | 112 | 2 | DOID:326 (implicated_via_orthology) | |
| Disease | Child Behaviour Checklist assessment | 2.10e-03 | 18 | 112 | 2 | EFO_0005661 | |
| Disease | Meckel syndrome type 1 | 2.10e-03 | 18 | 112 | 2 | C3714506 | |
| Disease | diet measurement, body mass index | 2.59e-03 | 20 | 112 | 2 | EFO_0004340, EFO_0008111 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 2.60e-03 | 150 | 112 | 4 | EFO_0004611, EFO_0020947 | |
| Disease | wellbeing measurement, alcohol consumption measurement | 2.84e-03 | 74 | 112 | 3 | EFO_0007869, EFO_0007878 | |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 2.84e-03 | 74 | 112 | 3 | DOID:3748 (is_marker_for) | |
| Disease | social deprivation, COVID-19 | 2.86e-03 | 21 | 112 | 2 | EFO_0009696, MONDO_0100096 | |
| Disease | mean corpuscular hemoglobin concentration | MORN1 CDK12 TSHR NEB SNX13 KAT2B NPHP3 PRKDC ENO2 TRIB1 SMAD7 | 3.23e-03 | 1105 | 112 | 11 | EFO_0004528 |
| Disease | myocardial infarction (biomarker_via_orthology) | 3.28e-03 | 160 | 112 | 4 | DOID:5844 (biomarker_via_orthology) | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | 3.50e-03 | 801 | 112 | 9 | EFO_0003888, EFO_0007052, MONDO_0002491 | |
| Disease | epilepsy (implicated_via_orthology) | 3.51e-03 | 163 | 112 | 4 | DOID:1826 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YFLLKNDGTFIGYKE | 26 | P31749 | |
| YFLLKSDGSFIGYKE | 26 | P31751 | |
| DFKKDKGAFYLVFEY | 801 | Q9NYV4 | |
| KGTTGYKAGFEYAFD | 366 | Q9NY47 | |
| YGGTKVVLDDKDYFL | 76 | P61604 | |
| KDYFLFRDGDILGKY | 86 | P61604 | |
| GFEKDVFKTIADYYG | 266 | Q8WUY9 | |
| FYRDGKYDLDFKSPT | 251 | P09104 | |
| KEKFFEDYYGQKLGL | 351 | Q8IXJ9 | |
| YFLLKTDGSFIGYKE | 26 | Q9Y243 | |
| AYERKDGKFVFFKGD | 371 | P50281 | |
| DEFKKIYANFFPYGD | 46 | P84074 | |
| EYAIGYFKKQGFSKD | 616 | Q92830 | |
| QGKLYGLEDLFYKYG | 311 | Q6ZNF0 | |
| AFLDKGEFYIGSKYK | 766 | P00450 | |
| HGKLLFKDGSYYEGA | 51 | Q5T089 | |
| DEYLLARFKGDGVKY | 36 | P98082 | |
| LDIFDYIYIDAFGKG | 341 | O94952 | |
| YKLFREKQKEGYGDA | 511 | Q6TGC4 | |
| AFGLYDGYKKAAVLK | 1466 | Q14667 | |
| KLFLAFGYDDELYVS | 236 | Q5VTA0 | |
| AAKLIDGEYKDYLAF | 911 | Q86UX2 | |
| EYAIGYFKKQGFSKE | 611 | Q92831 | |
| FRFAYYKLLKKADEG | 86 | Q96BI3 | |
| FTDLFEKKGYTFDYA | 311 | Q9HCP0 | |
| NYFFLYDGSKVKEEG | 16 | Q9NQG7 | |
| KFFREYEGKSFTYAA | 551 | Q5JUK3 | |
| DGYLFDRYKLGKVDQ | 316 | Q5JST6 | |
| VNDYILYYGGKKEDF | 81 | Q70Z53 | |
| LYYGGKKEDFKRLGE | 86 | Q70Z53 | |
| VKQKDFLDGVYAFEY | 501 | O75369 | |
| YGFVYELETGKQFLE | 111 | P20941 | |
| YQKFGFKTEEYVLDF | 746 | Q9H8E8 | |
| LLGKDKAFTYDFVFD | 41 | O75037 | |
| YFKLYDADGNGSIDK | 96 | O95843 | |
| DEFKKIYANFFPYGD | 46 | P37235 | |
| SEDKEEFVGYGQKFF | 361 | Q96JB8 | |
| DGEDYFLSLFGDSKK | 101 | Q8N9Z9 | |
| FFLKVTGYDKDDYLF | 401 | Q96RW7 | |
| GLFDEYGSKKSDYIK | 396 | P14625 | |
| FVLKGDQLYYFKDED | 41 | Q8N264 | |
| AKFLGTEDLYGYIDK | 246 | Q8NEV1 | |
| GFFEEEEGKEYIYKE | 1886 | Q96BY6 | |
| GGFAKYEKAFFTEEY | 1541 | Q92608 | |
| VSYIEKGLFKFVYGD | 201 | Q8WUS8 | |
| EYSKTFKGKYFNFLG | 276 | B7ZAQ6 | |
| EYSKTFKGKYFNFLG | 276 | P0CG08 | |
| IFNDGYKLSGFYKIK | 86 | Q08830 | |
| DDGTGIYFEKYILKD | 3231 | Q8N3K9 | |
| TYFYKKFGDFITLAN | 11 | Q14534 | |
| VKYKIISGNELGFFY | 611 | Q8TDW7 | |
| KSYQLYGKGFEDKLD | 1071 | Q5VT06 | |
| AGGLFAVSKKYFEYL | 311 | Q8IXK2 | |
| FKKFFDANYDGKDYD | 111 | Q15691 | |
| IDYFLEYFKGDTIAL | 566 | Q6ZN28 | |
| KLGDGFEGFYKSTYR | 171 | Q6P179 | |
| NVGFYKKFGYTVSEE | 161 | Q96EK6 | |
| IGFLVLFYKLYDGFS | 136 | Q6PEY0 | |
| YGDFFTGDAYVILKT | 86 | P06396 | |
| DFTGEQYILDKGFYT | 1371 | Q9Y4K1 | |
| RAYLEAYKEFKGFGT | 371 | Q9HBU6 | |
| YYRGFLTLEDFKKAF | 106 | Q9BUY7 | |
| DFEKIFAYYDVSKTG | 201 | O76038 | |
| KYYIEKLFERYGENG | 61 | Q9ULF5 | |
| FIYGKDVFEAFYKKD | 596 | Q13620 | |
| VENDGYKTIYFFGDK | 196 | O15305 | |
| YLSDGAEIKEKGFFY | 226 | P78382 | |
| YDFLENKAYSKGKGD | 681 | Q9Y5W8 | |
| SYDSYEILGKFVGKD | 1961 | O75691 | |
| QIIKVYGDKDADGFY | 881 | O15034 | |
| GSKYGIDEYLELKYV | 516 | P51649 | |
| SYEGGDFEKAAELYK | 1271 | Q7Z494 | |
| DFVSYFKGGLKYKAG | 106 | Q9Y6U3 | |
| AEAKEKIYLKGFYEG | 461 | Q9P2J5 | |
| EKFLTAYFAYKDGDI | 481 | Q5TEA6 | |
| DDEKLYFGLSYAKNG | 151 | O15530 | |
| FDGYIFLDSKGLEYP | 131 | Q9H1J1 | |
| SLDDFKGKYLVLFFY | 86 | P30048 | |
| YFEGEKRYLQAGKFF | 1016 | Q8NEZ3 | |
| YTDAGASFVFGEKYK | 266 | Q9HAS3 | |
| DFGFAIDKTIAYGYI | 856 | Q9UL12 | |
| EFLVAGGEDFKLYKY | 236 | Q9Y3F4 | |
| YAFGKYLGYLKIEFD | 281 | P21589 | |
| FEAFKDSEGYIYARG | 96 | Q03154 | |
| YARFEGDFKLFGYQK | 336 | O43529 | |
| GKEGLKFENGAFTYY | 571 | Q8NE01 | |
| TFDFKGVIDYIFYSK | 481 | Q96LI5 | |
| DGKKEKYFLFYDGET | 31 | Q4G0F5 | |
| KYFLFYDGETVSGKV | 36 | Q4G0F5 | |
| KGDYVYFGLTLFFVL | 156 | Q5GH73 | |
| FPGFSIKAFDYEKAY | 361 | O15105 | |
| KEDFSEAGNYLKGYV | 541 | Q9P2K2 | |
| CGLFYFSDEKYQKGI | 236 | Q8N609 | |
| LGETKAYVFFEKDFG | 151 | Q96RU8 | |
| YVELGQYGFALEDFK | 186 | Q86TZ1 | |
| GTYEDYLEGFRVFDK | 141 | P14649 | |
| DFIFAKEYRGSFSYK | 2906 | O60673 | |
| GFFKEGKYERAIECY | 291 | Q9H6T3 | |
| LSFLFEYIGEMGKDY | 1151 | O75533 | |
| FVYFAKALAEGYLKS | 51 | Q9NYB5 | |
| SGKVLYEGKEFDYVF | 391 | Q9Y263 | |
| LVTGFSKGYAFIEYK | 86 | Q16560 | |
| SNYKIKYFGFDDLSE | 446 | Q7Z5K2 | |
| KTEQFGKFGVIYYDI | 2116 | Q6N022 | |
| GLFAEKVYGFHKDYI | 101 | O75635 | |
| GKVEQFGKFGVIYYD | 2051 | Q9P273 | |
| YRGFTQDFKEKDGYK | 691 | O43290 | |
| EDFYILDQGGFKIYV | 281 | O15195 | |
| EFKIGELFSKFYGEL | 146 | P78527 | |
| TEDGKVEKHYLFYDG | 31 | O75436 | |
| KEGEEEYGFYSTLGK | 231 | Q9P272 | |
| FVDFSYTVGYKEGLL | 116 | Q96DR4 | |
| ENKYGKGIYFAKDAI | 811 | Q7Z2W4 | |
| GLLRFYTEEFDFKEY | 1191 | Q5TAX3 | |
| EFDFLGKDSIRYYNK | 526 | P11387 | |
| YVDTDAKDFADFGYK | 266 | Q96GX1 | |
| IGYDKFYASVQKLFG | 51 | B1ANS9 | |
| KYLTVIDKDAFGGVY | 211 | P16473 | |
| KNYKAEYEEDRGKGF | 456 | P20929 |